Ariela Hoxha Selected Research

Congenital heart block

1/2022	Short and long-term outcomes of children with autoimmune congenital heart block treated with a combined maternal-neonatal therapy. A comparison study.
7/2020	Fluorinated steroids are not superior to any treatment to ameliorate the outcome of autoimmune mediated congenital heart block: a systematic review of the literature and meta-analysis.
1/2019	First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).
1/2018	Detection of autoantibodies to the p200-epitope of SSA/Ro52 antigen. A comparison of two laboratory assays.
5/2017	Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
7/2016	Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study.
1/2016	Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients.
12/2015	Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block.
7/2015	Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ariela Hoxha Research Topics

Disease

24	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2022 - 09/2011
13	Thrombosis (Thrombus) 11/2022 - 09/2011
9	Congenital heart block 01/2022 - 07/2015
6	Pregnancy Complications 01/2022 - 12/2015
4	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 09/2011
3	Hemorrhage 01/2021 - 01/2017
3	Psoriatic Arthritis 11/2016 - 03/2016
2	Osteoarthritis 01/2021 - 03/2016
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 11/2015
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2018 - 01/2017
2	Pre-Eclampsia (Preeclampsia) 01/2018 - 01/2017
2	Joint Diseases (Joint Disease) 11/2016 - 03/2016
2	Rheumatoid Arthritis 03/2016 - 03/2016
2	Atrioventricular Block 03/2014 - 05/2013
1	Acute Disease 11/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2021
1	Weight Gain 01/2020
1	Neonatal Systemic lupus erythematosus 01/2019
1	Ischemic Stroke 01/2018
1	Atrial Fibrillation 01/2018
1	Fetal Death 01/2018
1	Myocardial Infarction 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Venous Thromboembolism 01/2018
1	Spontaneous Abortion (Miscarriage) 05/2017
1	Thrombotic Microangiopathies 05/2017
1	Congenital Diaphragmatic Hernias 03/2017
1	Rheumatic Diseases (Rheumatism) 03/2017
1	Thromboembolism 02/2017
1	Stillbirth 01/2017
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 11/2016
1	Sclerosing Cholangitis 11/2016
1	Gout 03/2016
1	Ankylosing Spondylitis 03/2016
1	Arthritis (Polyarthritis) 03/2016

Drug/Important Bio-Agent (IBA)

14	AntibodiesIBA 05/2019 - 09/2011
9	Antiphospholipid AntibodiesIBA 11/2022 - 01/2012
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2012
6	AutoantibodiesIBA 01/2019 - 03/2014
5	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 05/2013
5	Glycoproteins (Glycoprotein)IBA 02/2017 - 09/2011
4	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2012
4	Immunoglobulin G (IgG)IBA 05/2019 - 09/2011
4	Prothrombin (Factor II)IBA 05/2019 - 07/2015
4	Immunoglobulin M (IgM)IBA 05/2019 - 09/2011
3	PhosphatidylserinesIBA 05/2019 - 05/2017
3	Adalimumab (Humira)FDA Link 03/2017 - 03/2016
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2018
2	RivaroxabanIBA 01/2021 - 01/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 05/2017 - 06/2015
2	AnticoagulantsIBA 02/2017 - 01/2017
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2022
1	Complement System Proteins (Complement)IBA 11/2022
1	Vitamin K FDA Link 11/2022
1	AS 8IBA 09/2022
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 02/2021
1	GlucocorticoidsIBA 01/2021
1	Dabigatran FDA Link 01/2021
1	Fluorinated SteroidsIBA 07/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2018
1	RibonucleoproteinsIBA 05/2017
1	Biological ProductsIBA 03/2017
1	Factor Xa (Coagulation Factor Xa)IBA 02/2017
1	SuspensionsIBA 02/2017
1	Thrombin FDA Link 02/2017
1	Anticardiolipin AntibodiesIBA 01/2017
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2017
1	Calcium PyrophosphateIBA 03/2016
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 03/2016
1	Uric Acid (Urate)IBA 03/2016
1	SteroidsIBA 12/2015
1	Retinaldehyde (Retinal)IBA 11/2015
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 06/2015
1	Cardiolipins (Cardiolipin)IBA 06/2015
1	ImmunosorbentsIBA 06/2015
1	EnzymesIBA 06/2015
1	Betamethasone (Celestone)FDA Link 05/2013
1	Immunoglobulins (Immunoglobulin)IBA 09/2011

Therapy/Procedure

14	Therapeutics 11/2022 - 09/2011
2	Plasmapheresis 07/2016 - 05/2013
2	Blood Component Removal (Apheresis) 01/2016 - 12/2015
2	Plasma Exchange 07/2015 - 01/2012
1	Precision Medicine 02/2021
1	Renal Dialysis (Hemodialysis) 01/2018